Biomarker Adequacy Across Bronchoscopic Sampling Modalities Without Rapid Onsite Evaluation (ROSE): Experience with Pre-Analytical Workflow for Fine Needle Aspiration, Transbronchial Biopsy, and Cryobiopsy
Elsevier ·
Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.
Biomarker Adequacy Across Bronchoscopic Sampling Modalities Without Rapid Onsite Evaluation (ROSE): Experience with Pre-Analytical Workflow for Fine Needle Aspiration, Transbronchial Biopsy, and Cryobiopsy. // Journal of the American Society of Cytopathology. – URL: https://www.sciencedirect.com/science/article/pii/S2213294526002735?dgcid=rss_sd_all
Biomarker Adequacy Across Bronchoscopic Sampling Modalities Without Rapid Onsite Evaluation (ROSE): Experience with Pre-Analytical Workflow for Fine Needle Aspiration, Transbronchial Biopsy, and Cryobiopsy. Journal of the American Society of Cytopathology. https://www.sciencedirect.com/science/article/pii/S2213294526002735?dgcid=rss_sd_all
“Biomarker Adequacy Across Bronchoscopic Sampling Modalities Without Rapid Onsite Evaluation (ROSE): Experience with Pre-Analytical Workflow for Fine Needle Aspiration, Transbronchial Biopsy, and Cryobiopsy.” Journal of the American Society of Cytopathology.
@article{article31203,
title = {Biomarker Adequacy Across Bronchoscopic Sampling Modalities Without Rapid Onsite Evaluation (ROSE): Experience with Pre-Analytical Workflow for Fine Needle Aspiration, Transbronchial Biopsy, and Cryobiopsy},
journal = {Journal of the American Society of Cytopathology},
url = {https://www.sciencedirect.com/science/article/pii/S2213294526002735?dgcid=rss_sd_all}
}